Phosphorylation of Derivatives of β-Dialkyaminocrotonitriles with Phosphorus(III) Halides 199
3
1H, 4-Ph), 7.32 (t, JHH = 6.9 Hz, 2H, 3-Ph), 7.45 (d,
3 JHH = 6.9 Hz, 2H, 2-Ph). 13C NMR (CDCl3): δ = 23.1
(C(4)), 24.6 (CH2), 25.6 (CH2), 45.3 (PNCH2), 51.4
(NCH2), 53.0 (NCH2), 56.5 (1 JCP = 173 Hz, C(2)), 66.8
(3 JCP = 5.2 Hz, OCH2), 120.5 (C(2ꢁ)), 125.5 (C(4ꢁ)),
128.6 (C(3ꢁ)), 151.6 (C(1ꢁ)), 169.6 (2 JCP = 16 Hz,
C(3)). MS FAB, m/z (%): 458 (M + 1, 78), 354 (53).
338 (32), 252 (100), 204 (17), 165 (27), 154 (46), 136
(33), 105 (21), 75 (26). Anal. Calcd for C22H32N7O2P:
C 57.76, H 7.05, N 21.43, P 6.77. Found: C 57.42, H
6.93, N 21.12, P 6.41.
General Procedure for Preparation of
Iminophosphonates 6
Phosphothriazene 5 (0.5 g) was heated in vacuo to
170◦C for 30 min, affording iminophosphonate 6.
(2-[Dimorpholin-4-yl(phenyl)phosphorimidoyl]-
3-pyrrolidin-1-yl-but-2-enenitrile 6a. Brown solid
(0.45 g, 95%). Mp 87–92◦C. 31P NMR: δ = 17.1. H
1
NMR (CDCl3): δ = 1.89–2.03 (bm, 4H, CH2), 2.26
(s, 3H), 3.21–3.34 (m, 8H, PNCH2), 3.46–3.94 (bm,
12H, OCH2 (8H), NCH2 (4H)), 6.68 (t, 3 JHH = 7.2 Hz,
3
1H, 4-Ph), 6.75 (d, JHH = 7.2 Hz, 2H, 2-Ph), 7.08
2-{Dimorpholin-4-yl[3-(2-nitrophenyl)triaz-2-en-
ylidene]phosphoranyl}-3-pyrrolidin-1-yl-but-2-eneni-
trile 5b. Yellow solid (1.65 g, 45%). Mp 160–164◦C.
3
(t, JHH = 7.2 Hz, 2H, 3-Ph). 13C NMR (DMSOd6):
δ = 20.4 (C(4)), 24.4 (CH2), 25.4 (CH2), 45.0 (PNCH2),
50.7 (NCH2), 52.4 (NCH2), 58.4 (1 JCP = 171 Hz, C(2)),
66.5 (3 JCP = 6 Hz, OCH2), 116.2 (C(4ꢁ)), 121.5
(2 JCP = 9.9 Hz, CN), 122.4 (3 JCP = 16.4 Hz, C(2ꢁ)),
128.5 (C(3ꢁ)), 150.9 (C(1ꢁ)), 168.8 (2 JCP = 15.6 Hz,
C(3)). MS, m/z (%): 429 (M+, 22), 259 (100), 252
(63), 183 (28), 167 (54), 122 (52), 93 (66), 86 (52), 70
(17), 56 (16), 42 (14). Anal. Calcd for C22H32N5O2P:
C 61.52, H 7.51, N 16.31, P 7.21. Found: C 61.55, H
7.43, N 16.19, P 6.92.
31P NMR: δ = 44.3. H NMR (CDCl3): δ = 1.95–2.11
1
(m, 4H, CH2), 2.28 (s, 3H), 3.22–3.41 (m, 8H,
3
PNCH2), 3.59 (t, JHH = 6.6 Hz, 2H, NCH2), 3.63–
3
3.75 (m, 8H, OCH2), 3.97 (t, JHH = 6.6 Hz, 2H,
3
NCH2), 7.15 (t, JHH = 6.6 Hz, 1H, 4-Ph), 7.43 (d,
3 JHH = 6.6 Hz, 1H, 6-Ph), 7.46–7.52 (m, 2H, Ph).
13C NMR (CDCl3): δ = 22.8 (C(4)), 24.7 (CH2), 25.7
(CH2), 45.2 (PNCH2), 51.7 (NCH2), 53.5 (NCH2),
56.0 (1 JCP = 166 Hz, C(2)), 66.8 (3 JCP = 5 Hz, OCH2),
120.6 (2 JCP = 8.8 Hz, CN), 123.7, 124.4, 125.2, 131.6,
143.2 (C(1ꢁ)), 145.2 (C(2ꢁ)), 170.2 (2 JCP = 18.9 Hz,
C(3)). MS FAB, m/z (%): 503 (M + 1, 72), 354 (23),
338 (41), 252 (100), 204 (16), 165 (24), 154 (42), 136
(37). Anal. Calcd for C22H31N8O4P: C 52.58, H 6.22,
N 22.30, P 6.16. Found: C 52.42, H 6.29, N 22.48, P
6.01.
2-[Dimorpholin-4-yl(2-nitrophenyl)phosphorimi-
doyl]-3-pyrrolidin-1-yl-but-2-enenitrile 6b. Brown
solid (0.47 g, 93%). Mp 98–103◦C. 31P NMR: δ = 18.5.
1H NMR (CDCl3): δ = 1.90–2.06 (bm, 4H, CH2), 2.19
(s, 3H), 3.18–3.38 (m, 8H, PNCH2), 3.41–3.56 (bm,
2H, NCH2), 3.58–3.79 (m, 8H, OCH2), 3.81–3.95 (bm,
3
2H, NCH2), 6.62 (t, JHH = 7.2 Hz, 1H, 4-Ph), 6.79
3
3
(d, JHH = 7.2 Hz, 1H, 6-Ph), 7.18 (td, JHH = 7.2 Hz,
2-[[3-(5-Chloro-2-methoxyphenyl)triaz-2-enylid-
ene](dimorpholin-4-yl)phosphoranyl]-3-pyrrolidin-1-
yl-but-2-enenitrile 5c. Orange solid (1.4 g, 37%). Mp
4 JHH = 1.5 Hz, 1H, 5-Ph), 7.58 (ddd, JHH = 7.2 Hz,
3
4 JHH = 1.5 Hz, JPH = 1.5 Hz, 1H, 3-Ph). 13C NMR
5
145–147◦C. 31P NMR: δ = 44.3. H NMR: δ = 1.96–
1
(CDCl3): δ = 20.8 (C(4)), 24.7 (CH2), 25.8 (CH2),
45.2 (PNCH2), 51.2 (NCH2), 52.8 (NCH2), 58.9
(1 JCP = 167 Hz, C(2)), 67.1 (3 JCP = 7.5 Hz, OCH2),
115.6 (C(4ꢁ)), 121.4 (2 JCP = 11.3 Hz, CN), 124.5
(3 JCP = 8.8 Hz, C(6ꢁ)), 124.8 (C(5ꢁ)), 132.2 (C(3ꢁ)),
144.2 (2 JCP = 22.6 Hz, C(1ꢁ)), 144.9 (3 JCP = 8.8 Hz,
C(2ꢁ)), 169.0 (2 JCP = 16.3 Hz, C(3)). MS, m/z (%):
474 (M+, 1), 457 (7), 287 (57), 199 (64), 183
(52), 136 (100), 86 (85), 70 (66), 56 (58), 42 (42).
Anal. Calcd for C22H31N6O4P: C 55.69, H 6.59, N
17.71, P 6.53. Found: C 55.75, H 6.40, N 17.32,
P 6.35.
2.14 (m, 4H, CH2), 2.25 (s, 3H), 3.19–3.40 (m,
3
8H, PNCH2), 3.54 (t, JHH = 6.9 Hz, 2H, NCH2),
3.65–3.75 (m, 8H, OCH2), 3.86 (s, 1H, OCH3), 3.94
3
3
(t, JHH = 6.9 Hz, 2H, NCH2), 6.85 (d, JHH = 8.7 Hz,
1H, 3-Ph), 7.06 (dd, 3 JHH = 8.7 Hz, 4 JHH = 3.0 Hz, 1H,
4-Ph), 7.15 (d, JHH = 3.0 Hz, 1H, 6-Ph). 13C NMR
4
(CDCl3): δ = 23.5 (C(4)), 24.7 (CH2), 25.7 (CH2), 45.2
(PNCH2), 51.5 (NCH2), 53.2 (NCH2), 55.9 (OCH3),
56.3 (1 JCP = 162 Hz, C(2)), 66.9 (3 JCP = 4.3 Hz, OCH2),
113.0 (C(3ꢁ)), 116.4 (C(4ꢁ)), 120.6 (2 JCP = 8.8 Hz, CN),
125.2 (C(6ꢁ)), 125.4 (C(5ꢁ)), 142.4 (C(1ꢁ)), 152.2
(C(2ꢁ)), 169.8 (2 JCP = 17.6 Hz, C(3)). MS FAB,
m/z (%): 522 (M + 1, 25), 494 (56), 354 (19), 338
(32), 252 (100), 204 (17), 169 (13), 165 (32), 154 (13),
136 (16). Anal. Calcd for C23H33ClN7O3P: C 52.92,
H 6.37, N 18.78, P 5.93. Found: C 52.64, H 6.43, N
18.60, P 5.73.
2-[(5-Chloro-2-methoxyphenyl)(dimorpholin-4-yl)-
phosphorimidoyl]-3-pyrrolidin-1-yl-but-2-enenitrile
6c. Yellow solid (0.45 g, 95%). Mp 75–80◦C. 31P
NMR: δ = 17.0. 1H NMR: δ = 1.93–2.05 (bm, 4H,
CH2), 2.11 (s, 3H), 3.21–3.37 (m, 8H, PNCH2),
Heteroatom Chemistry DOI 10.1002/hc